The Journal of the Association of Physicians of India · 2026
Cardiac Magnetic Resonance Imaging Study on Cardiovascular Involvement >60 Days Post COVID-19 Recovery.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mehta Nihar, Banerjee Tanushree Somir, Karnavat Chandresh O, Parikh Rajesh M, Kashikar Ritu, Sinhasan Shraddha, Tandan-Pardasani Shruti, Bindroo Susheel, Bhabhor Anand, Raut Indraneil, Shah Nimish, Desai Shrinivas B, Kapadia Munira, Desai Maherra, Kapoor Aarshee
Аннотация
CONTEXT: This study evaluates individuals who have recovered from coronavirus disease 2019 (COVID-19) for cardiac manifestations at least 60 days postrecovery, using cardiac magnetic resonance (CMR) imaging. Native T1, native T2, and late gadolinium enhancement (LGE) were used as parameters to detect potential cardiac pathologies.
AIM: To study the incidence and nature of cardiac manifestations in long COVID using CMR.
STUDY DESIGN: Prospective observational study.
METHODS: A total of 54 COVID-19-recovered patients and 50 healthy matched controls (age- and sex-based) underwent CMR using a 3 T scanner. Pathologies were assessed through native T1 and T2 mapping and LGE imaging. Data analysis was conducted using SPSS version 23.
RESULTS: Only 1 patient (1.85%) showed midmyocardial LGE in the basal and midinferior segments, along with raised native T1 and T2 values. The remaining 53 recovered patients (98.15%) revealed no LGE or elevated T1/T2 values compared to controls. Native T1 and T2 values did not significantly differ between the post-COVID participants and healthy controls. Mild concentric hypertrophy was observed in six patients, which appeared incidental and unrelated to COVID-19. None of the patients exhibited elevated troponin T levels.
CONCLUSION: In this study, CMR imaging did not find a significant increase in cardiac manifestations that may be attributed to long COVID in patients who had recovered from COVID-19 compared with uninfected controls. We believe the incidence of cardiovascular comorbidities related to long COVID syndrome is much lower in the Indian population than reported in Western literature. These findings are reassuring and may help alleviate concerns among the Indian population regarding long-term cardiovascular involvement of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
AIM: To study the incidence and nature of cardiac manifestations in long COVID using CMR.
STUDY DESIGN: Prospective observational study.
METHODS: A total of 54 COVID-19-recovered patients and 50 healthy matched controls (age- and sex-based) underwent CMR using a 3 T scanner. Pathologies were assessed through native T1 and T2 mapping and LGE imaging. Data analysis was conducted using SPSS version 23.
RESULTS: Only 1 patient (1.85%) showed midmyocardial LGE in the basal and midinferior segments, along with raised native T1 and T2 values. The remaining 53 recovered patients (98.15%) revealed no LGE or elevated T1/T2 values compared to controls. Native T1 and T2 values did not significantly differ between the post-COVID participants and healthy controls. Mild concentric hypertrophy was observed in six patients, which appeared incidental and unrelated to COVID-19. None of the patients exhibited elevated troponin T levels.
CONCLUSION: In this study, CMR imaging did not find a significant increase in cardiac manifestations that may be attributed to long COVID in patients who had recovered from COVID-19 compared with uninfected controls. We believe the incidence of cardiovascular comorbidities related to long COVID syndrome is much lower in the Indian population than reported in Western literature. These findings are reassuring and may help alleviate concerns among the Indian population regarding long-term cardiovascular involvement of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.